| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0053 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |